Kramer Kelly A.
Reporting owner on Forms 3, 4 and 5, CIK 1629885.
Kramer Kelly A. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| GILD · GILEAD SCIENCES, INC.CIK 882095 | director | 1 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| GILD · GILEAD SCIENCES, INC.Common Stock | 2026-11-12 | M exercised | +10,376 | $66.92 | 11,715 | Form 4 |
| GILD · GILEAD SCIENCES, INC.Common Stock | 2026-11-12 | S sold | -1,676 | $168.2255 | 10,039 | Form 4 |
| GILD · GILEAD SCIENCES, INC.Common Stock | 2026-11-12 | S sold | -3,800 | $169.4423 | 6,239 | Form 4 |
| GILD · GILEAD SCIENCES, INC.Common Stock | 2026-11-12 | S sold | -4,700 | $170.4941 | 1,539 | Form 4 |
| GILD · GILEAD SCIENCES, INC.Common Stock | 2026-11-12 | S sold | -200 | $171.44 | 1,339 | Form 4 |
| GILD · GILEAD SCIENCES, INC.Non-qualified Stock Option (Right to Bu…, derivative | 2026-11-12 | M exercised | -10,376 | $0 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001629885-26-000008 | GILEAD SCIENCES, INC. | 2026-11-16 |